Abeona Therapeutics Inc(NASDAQ:ABEO) 
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead programs include EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, an adeno-associated...
Website: http://www.abeonatherapeutics.com
Founded: 1974
Full Time Employees: 88
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 4.94
H 4.99
L 4.40
C 4.52
V 745,786
10EMA 4.52
20EMA 4.52
60EMA 4.52
120EMA 4.52
250EMA 4.52